Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrea June Kriz, Ph.D.

Concepts (82)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Andrea Kriz's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andrea Kriz has written about over time.
Polyadenylation, 2 publications between 2013 and 2018, average publication date October 2015. Ribonucleoprotein, U1 Small Nuclear, 2 publications between 2013 and 2018, average publication date October 2015. Embryonic Stem Cells, 5 publications between 2014 and 2021, average publication date November 2018. G2 Phase, 1 publications between 2019 and 2019, average publication date January 2019. Phosphoserine, 1 publications between 2019 and 2019, average publication date January 2019. Gene Silencing, 3 publications between 2018 and 2021, average publication date October 2019. Nucleic Acid Conformation, 2 publications between 2018 and 2021, average publication date January 2020. Cell Cycle Proteins, 2 publications between 2019 and 2021, average publication date February 2020. X Chromosome Inactivation, 5 publications between 2018 and 2021, average publication date May 2020. Endoribonucleases, 1 publications between 2020 and 2020, average publication date August 2020. X Chromosome, 4 publications between 2019 and 2021, average publication date September 2020. Chromosomal Proteins, Non-Histone, 1 publications between 2021 and 2021, average publication date March 2021. Chromosomes, 1 publications between 2021 and 2021, average publication date November 2021.

To see the data from this visualization as text, click here.
Kriz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.